Safety of combined intravenous beta-adrenergic blockade (atenolol or metoprolol) and thrombolytic therapy in acute myocardial infarction

This publication has 10 references indexed in Scilit:

• Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.
  Circulation, 1991
• Coronary reperfusion by thrombolysis and early beta-adrenergic blockade in acute experimental myocardial infarction
  Journal of the American College of Cardiology, 1989
• Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1989
• Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with beta-adrenergic blockade with metoprolol.
  Circulation, 1987
• DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS PLACEBO IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985
• Long-term treatment with metoprolol after myocardial infarction: Effect on 3 year mortality and morbidity
  Journal of the American College of Cardiology, 1985
• Beta blockade during and after myocardial infarction: An overview of the randomized trials
  Progress in Cardiovascular Diseases, 1985
• Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol)
  Journal of the American College of Cardiology, 1984
• A Randomized Trial of Propranolol in Patients With Acute Myocardial Infarction
  JAMA, 1982
• Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial Infarction
  New England Journal of Medicine, 1981